HTML-редакторПеренос слов

Moscow, July 17, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the «Company») announces that pursuant to the Company’s buyback program, announced on February 15, 2013 (further the «Program»), 15 009 162 GDRs and 140 000 ordinary shares were purchased on the open market as of July 16, 2013. All purchases of GDRs were made by an independent broker Citigroup Global Markets Limited for the account of Pharmstandard-Leksredstva OJSC, an indirect wholly owned subsidiary of the Company.

Therefore, since the start of Pharmstandard’s buyback program the following securities have been purchased:

Date	Type	Amount (shares)		Price per share		Amount
				USD	RUR	USD	RUR
22/04/13	GDR		220 000	20,4659	643,87	4 502 498,00	141 650 838,33
26/04/13	GDR		3 056 305	20,4000	638,86	62 348 622,00	1 952 565 560,31
20/06/13	ORDS		140 000	65,4082	2 150,00	9 157 148,00	301 000 000,00
26/06/13	GDR		1 718 574	20,3500	665,73	34 972 980,90	1 144 106 097,16
26/06/13	GDR		115 421	20,5500	672,27	2 371 901,55	77 594 387,31
09/07/13	GDR		364 000	16,8500	561,46	6 133 400,00	204 371 021,40
10/07/13	GDR		2 833 075	15,8500	528,14	44 904 238,75	1 496 254 139,39
11/07/13	GDR		3 000 000	11,9000	387,78	35 700 000,00	1 163 345 190,00
12/07/13	GDR		1 100 000	10,9500	356,82	12 045 000,00	392 506 801,50
15/07/13	GDR		410 000	12,9000	421,09	5 289 000,00	172 648 298,10
16/07/13	GDR		2 191 787	13,6000	443,66	29 808 303,20	972 406 466,99
Total :			15 149 162			247 233 092,40	8 018 448 800,49

The last buy-back took place on July 16: 2 191 787 GDRs at the price of 13,60 USD per GDR.

The Program was approved in respect of ordinary shares of Pharmstandard OJSC and/or Global Depositary Receipts representing Shares (each Share representing 4 GDRs) in the aggregate amount of up to RUR8 billion. Duration of program: December 31, 2013.

The total sum of securities purchased as of July 16, 2013 constitutes RUR 8 018 448 800,49, hence, the Programs may be considered as completed.

New shareholder structure is as follows:

Augment Investments Limited – 54,3185% (ordinary shares and GDRs)

LSE – 17,64% (GDRs)

RTS/MICEX – 9,31% (ordinary shares)

Pharmstandard-Leksredstva OJSC – 18,7392% % (ordinary shares and GDRs) 

Regards,
Irina Bakhturina
Investor Relations
Pharmstandard OJSC
Tel.   (495) 970-0030 ext.2824
Fax   (495) 970-0032
www.pharmstd.ru

ИзменитьОтмена